| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
931,071,000 as of 6/30 |
| Market
Cap: |
52.07(B) |
| Last
Volume: |
3,987,584 |
Avg
Vol: |
6,310,844 |
| 52
Week Range: |
$41.95 - $55.55 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Diversified Chemicals |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 561 |
| Guru Rank Value : -1.2 |
| Guru Occurances : 5 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile Du Pont (E.I.) de Nemours & Co consists of 14 businesses which are aggregated into nine reportable segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Chemicals, Performance Coatings, Performance Materials, Safety & Protection and Pharmaceuticals. Co.'s products include, but are not limited to, corn hybrids, soybean varieties, herbicides, insecticides, photopolymers, electronic materials, enzymes, cultures, emulsifiers, natural sweeteners, fluorochemicals, fluoropolymers, specialty chemicals, white pigments, automotive finishes, industrial coatings, engineering polymers, and its interest in the Cozaar®/Hyzaar® antihypertensive drugs.
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
5,290 |
| Total Buy Value |
$0 |
$0 |
$0 |
$270,850 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
578,491 |
762,865 |
881,432 |
1,239,646 |
| Total Sell Value |
$31,355,459 |
$40,063,965 |
$46,018,670 |
$63,770,713 |
| Total People Sold |
7 |
8 |
8 |
10 |
| Total Sell Transactions |
12 |
21 |
24 |
37 |
| End Date |
2013-02-21 |
2012-11-20 |
2012-05-22 |
2011-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Vergnano Mark P |
Executive Vice President |
|
2013-05-20 |
4 |
OE |
$44.74 |
$2,180,762 |
D/D |
48,743 |
162,506 |
|
- |
|
Vergnano Mark P |
Executive Vice President |
|
2013-05-20 |
4 |
AS |
$56.00 |
$2,729,608 |
D/D |
(48,743) |
113,763 |
|
- |
|
Kullman Ellen Jamison |
Chair & CEO |
|
2013-05-10 |
4 |
OE |
$44.74 |
$4,952,360 |
D/D |
110,692 |
506,268 |
|
- |
|
Kullman Ellen Jamison |
Chair & CEO |
|
2013-05-10 |
4 |
AS |
$55.08 |
$6,097,270 |
D/D |
(110,692) |
395,576 |
|
0% |
|
Kullman Ellen Jamison |
Chair & CEO |
|
2013-05-10 |
4 |
OE |
$44.74 |
$274,390 |
I/I |
6,133 |
16,091 |
|
- |
|
Kullman Ellen Jamison |
Chair & CEO |
|
2013-05-10 |
4 |
AS |
$55.03 |
$337,509 |
I/I |
(6,133) |
9,958 |
|
0% |
|
Connelly Thomas M Jr |
Executive Vice President |
|
2013-05-10 |
4 |
OE |
$23.28 |
$1,593,200 |
D/D |
50,000 |
206,851 |
|
- |
|
Connelly Thomas M Jr |
Executive Vice President |
|
2013-05-10 |
4 |
AS |
$55.08 |
$2,753,960 |
D/D |
(50,000) |
176,851 |
|
0% |
|
Fanandakis Nicholas C |
Executive Vice President & CFO |
|
2013-05-09 |
4 |
OE |
$44.74 |
$1,209,993 |
D/D |
27,045 |
169,438 |
|
- |
|
Fanandakis Nicholas C |
Executive Vice President & CFO |
|
2013-05-09 |
4 |
AS |
$55.00 |
$1,487,475 |
D/D |
(27,045) |
142,393 |
|
0% |
|
Sager Thomas L |
SVP and General Counsel |
|
2013-05-09 |
4 |
OE |
$44.74 |
$984,862 |
D/D |
22,013 |
68,860 |
|
- |
|
Sager Thomas L |
SVP and General Counsel |
|
2013-05-09 |
4 |
AS |
$55.00 |
$1,210,715 |
D/D |
(22,013) |
46,847 |
|
0% |
|
Crawford Curtis J |
Director |
|
2013-04-30 |
4 |
A |
$54.51 |
$4,167 |
D/D |
76 |
37,957 |
|
- |
|
Cutler Alexander M |
Director |
|
2013-04-30 |
4 |
A |
$54.51 |
$10,000 |
D/D |
183 |
39,925 |
|
- |
|
Juliber Lois D |
Director |
|
2013-04-30 |
4 |
A |
$54.51 |
$5,000 |
D/D |
92 |
53,692 |
|
- |
|
Collomb Bertrand P |
Director |
|
2013-04-30 |
4 |
A |
$54.51 |
$2,500 |
D/D |
46 |
22,236 |
|
- |
|
Brown Richard H |
Director |
|
2013-04-30 |
4 |
A |
$54.51 |
$8,333 |
D/D |
153 |
45,792 |
|
- |
|
Borel James C |
Executive Vice President |
|
2013-04-30 |
4 |
OE |
$44.74 |
$1,208,875 |
D/D |
27,020 |
153,638 |
|
- |
|
Borel James C |
Executive Vice President |
|
2013-04-30 |
4 |
AS |
$54.00 |
$1,459,080 |
D/D |
(27,020) |
126,618 |
|
2% |
|
Kullman Ellen Jamison |
Chair & CEO |
|
2013-04-29 |
4 |
S |
$53.80 |
$6,759,205 |
D/D |
(125,629) |
395,576 |
|
-3% |
|
Connelly Thomas M Jr |
Executive Vice President |
|
2013-04-26 |
4 |
OE |
$23.28 |
$2,040,600 |
D/D |
60,000 |
210,318 |
|
- |
|
Connelly Thomas M Jr |
Executive Vice President |
|
2013-04-26 |
4 |
S |
$52.91 |
$3,888,499 |
D/D |
(73,467) |
176,851 |
|
-5% |
|
Sager Thomas L |
SVP and General Counsel |
|
2013-04-26 |
4 |
S |
$52.02 |
$398,176 |
D/D |
(7,654) |
46,847 |
|
-5% |
|
Borel James C |
Executive Vice President |
|
2013-04-25 |
4 |
OE |
$44.74 |
$2,505,440 |
D/D |
56,000 |
168,789 |
|
- |
|
Borel James C |
Executive Vice President |
|
2013-04-25 |
4 |
AS |
$52.84 |
$3,709,876 |
D/D |
(70,171) |
126,618 |
|
5% |
|
1394 Records found
|
|
Page 1 of 56 |
|
|